Login / Signup

Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial.

Samer Al HadidiFrits Van Rhee
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • randomized controlled trial
  • double blind